ASH News Daily 2017 - Issue 3 - B-26

ASH News Daily

Page B-26

Monday, December 11, 2017

Monday Product Theater Schedule

roduct Theaters feature exhibitor presentations on
new research findings and
products to small groups of annual meeting attendees (no more
than 150) within the exhibit hall
(Building B, Level 1, Halls B2-B4).
The Product Theater sessions will
be solely promotional in nature;
therefore, continuing medical education credits will not be offered.
ASH will provide lunch during
each theater. Please bring your
Sunday and/or Monday exhibit

hall lunch ticket to the applicable
product theater.
Today - 12:15 p.m. to 1:15 p.m.
Product Theater #1
(back of the 200 aisle)
Discover the Role of Two Immunotherapies in Myeloma Treatment
Sponsored by: Celgene Corporation
Speaker: Amit Agarwal, MD, Senior Medical Director, Celgene Corporation
*This presentation is intended
for U.S.-based attendees

Product Theater #2
(back of the 900 aisle)
Improving Outcomes in Patients
With Newly-Diagnosed AML
Sponsored by: Jazz Pharmaceuticals, Inc.
Speaker: Allen S. Yang, MD,
PhD, Hematology/Oncology Therapeutic Area Head, Clinical Development, Jazz Pharmaceuticals, Inc.
*This presentation is intended
for U.S.-based attendees
Product Theater #3
(back of the 2900 aisle)

Cancer is smart...and relentless. At Dana-Farber, we are too. Each year, we conduct over 800 clinical trials

THink like
giving patients access to the latest advances. And, in partnership with Brigham and Women's Hospital

cancer
and Boston Children's Hospital, we're mapping out the genetic weaknesses of 25,000+ tumors to create

to beat
precision treatments that destroy cancer. These are just a few reasons why U.S. News & World Report

cancer
has recognized us as a national leader in cancer for 17 years straight. It's also why, here, cancer is quickly losing ground.

Let's beat cancer...once and for all.
Visit dana-farber.org/beatcancer

Visit us at booth #1642.

Important Update on Congenital
Plasminogen Deficiency
Sponsored by: Prometic Life Sciences Inc.
Speaker: John Moran, MD, Chief
Medical Officer, Prometic Life Sciences Inc.
*This presentation is intended
for U.S.-based attendees
Product Theater #4
(back of the 3300 aisle)
Therapeutic antibodies in the use of
Hemophilia A
Sponsored by: Genentech USA, Inc.
Speaker: Richard Ko, MD, MHS,
MS, Associate Medical Director,
Genentech, Inc., A Member of the
Roche Group
*This presentation is intended
for U.S.-based attendees
Product Theater #5
(front of the 500 aisle)
Clinical Impact of Overall Survival
as an Endpoint of Therapy for Hematologic Malignancies
Sponsored by: Amgen
Speaker: Janet Franklin, MD,
MPH, Executive Medical Director,
Global Development Lead, Amgen;
Amy Kimball, MD, PhD, Clinical
Research Medical Director, Amgen
*This presentation is intended
for U.S.-based attendees

Final Day to Visit
the Exhibit Hall

isit the state-of-the-art exhibit hall, located in the Georgia World Congress Center,
Building B, Level 1, Halls B2-B4,
to see the latest technology and research and to learn about the wide
range of products and services offered by more than 250 exhibitors
present this year. Exhibitors will
include pharmaceutical companies,
medical suppliers, clinical diagnostic and research-based companies,
publishers, and nonprofit organizations. ASH will provide a complimentary light lunch from 12:00 noon
to 1:30 p.m. this afternoon.
While you're there, be sure to visit
the ASH Booth (#1933) to get the latest information on grants, awards,
publications, educational materials,
and ASH regional meetings available
to hematologists around the world.
Our friendly staff will be glad to answer your questions, discuss how
you can get involved with ASH, and
hear your feedback about the annual
meeting. Be sure to stop by and pick
up a giveaway and the most recent
issues of ASH Clinical News, Blood,
The Hematologist, and Blood Advances.
Exhibit Hall Hours:
Monday, December 11
10:00 a.m. - 2:00 p.m.

Table of Contents for the Digital Edition of ASH News Daily 2017 - Issue 3